The present invention relates to compounds according to formula (1) and formula (2), said compounds being suitable for use in electronic devices, in particular organic electroluminescent devices.

The present invention provides a novel compound having antiviral activity, especially HIV replication inhibitory activity and a medicament containing the same. The compound represented by the formula:

##STR00001##

wherein A.sup.3 is CR.sup.3A, CR.sup.3AR.sup.3B, N or NR.sup.3C; R.sup.3A, R.sup.3B, R.sup.4A and R.sup.4B are each independently a hydrogen atom, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkynyl, or substituted or unsubstituted non-aromatic carbocyclyl; R.sup.3C is a hydrogen atom, substituted or unsubstituted alkyl, or substituted or unsubstituted non-aromatic carbocyclyl; ring T.sup.1 is substituted or unsubstituted nitrogen-containing non-aromatic heterocycle; R.sup.1 is a hydrogen atom, halogen, cyano, or substituted or unsubstituted alkyl; R.sup.2 is each independently substituted or unsubstituted alkyl or the like: n is 1 or 2; R.sup.3 is substituted or unsubstituted aromatic carbocyclyl or the like; R.sup.4 is a hydrogen atom or a carboxy protecting group.

The present invention provides a novel compound having antiviral activity, especially HIV replication inhibitory activity and a medicament containing the same. The compound represented by the formula:

##STR00001##

wherein A.sup.3 is CR.sup.3A, CR.sup.3AR.sup.3B, N or NR.sup.3C; R.sup.3A, R.sup.3B, R.sup.4A and R.sup.4B are each independently a hydrogen atom, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkynyl, or substituted or unsubstituted non-aromatic carbocyclyl; R.sup.3C is a hydrogen atom, substituted or unsubstituted alkyl, or substituted or unsubstituted non-aromatic carbocyclyl; ring T.sup.1 is substituted or unsubstituted nitrogen-containing non-aromatic heterocycle; R.sup.1 is a hydrogen atom, halogen, cyano, or substituted or unsubstituted alkyl; R.sup.2 is each independently substituted or unsubstituted alkyl or the like: n is 1 or 2; R.sup.3 is substituted or unsubstituted aromatic carbocyclyl or the like; R.sup.4 is a hydrogen atom or a carboxy protecting group.

The present invention provides a novel compound having antiviral activity, especially HIV replication inhibitory activity and a medicament containing the same. The compound represented by the formula: ##STR00001##
wherein A.sup.3 is CR.sup.3A, CR.sup.3AR.sup.3B, N or NR.sup.3C; R.sup.3A, R.sup.3B, R.sup.4A and R.sup.4B are each independently a hydrogen atom, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkynyl, or substituted or unsubstituted non-aromatic carbocyclyl; R.sup.3C is a hydrogen atom, substituted or unsubstituted alkyl, or substituted or unsubstituted non-aromatic carbocyclyl; ring T.sup.1 is substituted or unsubstituted nitrogen-containing non-aromatic heterocycle; R.sup.1 is a hydrogen atom, halogen, cyano, or substituted or unsubstituted alkyl; R.sup.2 is each independently substituted or unsubstituted alkyl or the like: n is 1 or 2; R.sup.3 is substituted or unsubstituted aromatic carbocyclyl or the like; R.sup.4 is a hydrogen atom or a carboxy protecting group.

The present invention provides a novel compound having antiviral activity, especially HIV replication inhibitory activity and a medicament containing the same. The compound represented by the formula: ##STR00001##
wherein A.sup.3 is CR.sup.3A, CR.sup.3AR.sup.3B, N or NR.sup.3C; R.sup.3A, R.sup.3B, R.sup.4A and R.sup.4B are each independently a hydrogen atom, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkynyl, or substituted or unsubstituted non-aromatic carbocyclyl; R.sup.3C is a hydrogen atom, substituted or unsubstituted alkyl, or substituted or unsubstituted non-aromatic carbocyclyl; ring T.sup.1 is substituted or unsubstituted nitrogen-containing non-aromatic heterocycle; R.sup.1 is a hydrogen atom, halogen, cyano, or substituted or unsubstituted alkyl; R.sup.2 is each independently substituted or unsubstituted alkyl or the like: n is 1 or 2; R.sup.3 is substituted or unsubstituted aromatic carbocyclyl or the like; R.sup.4 is a hydrogen atom or a carboxy protecting group.

Provided are an organic compound represented by Formula 1 and an optoelectronic device including an optical activation layer including the organic compound represented by Formula 1:

##STR00001##

where, in Formula 1, Q is an electron-withdrawing group.

Provided are an organic compound represented by Formula 1 and an optoelectronic device including an optical activation layer including the organic compound represented by Formula 1:

##STR00001##

where, in Formula 1, Q is an electron-withdrawing group.

Processes for preparing compounds of Formula (1) and Formula (2) are described, wherein X, Y, Z, R.sub.1-R.sub.7, L and n are defined herein. Intermediates useful in the preparation of the compounds of Formula (1) and Formula (2) are also described.

##STR00001##

Processes for preparing compounds of Formula (1) and Formula (2) are described, wherein X, Y, Z, R.sub.1-R.sub.7, L and n are defined herein. Intermediates useful in the preparation of the compounds of Formula (1) and Formula (2) are also described.

##STR00001##

The present invention relates to a pyridinium oxazole dyad scaffold of formula (I) and a process for the preparation thereof. The present invention further discloses a pyridine compound of formula (II) which is used for the preparation of formula (I) and a process for preparation thereof.

##STR00001##